Publication:

Assess the acceptance and compliance of injectable contraceptive depot medroxyprogestrone acetate

Background The use of safe and effective contraception is the need of the hour in India, with one of the world’s largest and fastest growing population. Assessing the acceptance and compliance of women for temporary contraception DMPA. Acceptance shall be compared between different reproductive age group, different parity and among lactating/non lactating female.

Methods In this study, 100 women have been taken, those were appropriate within the inclusion criteria for the period of one year. Injection DMPA 150 mg injected intramuscularly every 3 months and used questionnaire method for assessing the acceptance and compliance of women for temporary contraception DMPA.

Results Injectable contraceptive DMPA is safe, convenient, efficacious and effective long term contraceptive. It is acceptable to women when offered with quality counselling and follow up care. Acceptance of DMPA, was found that there is no need of daily administration of DMPA in 51% of women, 10% women found it’s easy to administer via intramuscular injection, lactating female can breast feed also as it possess no changes in breast milk.

Conclusions DMPA is highly efficacious, safe and effective method of contraception requiring less frequent dosing and can be used in lactating female. Women who received information on DMPA safety, efficacy and side effects are more likely to continue DMPA use.